tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Compare Immunovant (IMVT) vs. Competitors

927 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$24.61
$5.03B
-10.43
85.80%
10 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$102.09
$6.51B
-42.66
145.00%
10 Buy
1 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$39.96
$4.18B
-8.91
56.34%
8 Buy
0 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$95.65
$5.91B
-169.72
149.11%
9 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$87.13
$7.11B
-21.09
313.92%
17 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$17.08
$1.33B
-3.74
-43.35%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
24.73
9.83
65.97%
PTGX
Protagonist Therapeutics
102.09
59.52
139.82%
CRNX
Crinetics Pharmaceuticals
39.96
12.30
44.47%
MIRM
Mirum Pharmaceuticals
97.95
56.48
136.19%
KYMR
Kymera Therapeutics
87.13
63.18
263.80%
MLTX
MoonLake Immunotherapeutics
18.60
-17.38
-48.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts